Development and characterization of erythrosine nanoparticles with potential for treating sinusitis using photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 12, Issue 1, 2015, Pages 9-18

  Garapati, Chandrasekhar ^a   Clarke, Brandon ^b   Zadora, Steven ^c   Burney, Charles ^c   Cameron, Brent D ^b   Fournier, Ronald ^b   Baugh, Reginald F ^c   Boddu, Sai H S ^a  

^a UNIVERSITY OF TOLEDO   (United States)

^b Toledo   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Erythrosine; Photodynamic therapy; PLGA nanoparticles; Sinusitis; Staphylococcus aureus

Indexed keywords

ERYTHROSINE; POLY LACTIC CO GLYCOLIC ACID; POLYMER; UNCLASSIFIED DRUG; NANOCAPSULE; PHOTOSENSITIZING AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG UPTAKE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SCANNING ELECTRON MICROSCOPY; SINUSITIS; STAPHYLOCOCCUS AUREUS; SURFACE CHARGE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DIFFUSION; DRUG EFFECTS; HUMAN; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; STAPHYLOCOCCAL INFECTIONS; ULTRASTRUCTURE;

STAPHYLOCOCCUS AUREUS;

CELL SURVIVAL; DIFFUSION; ERYTHROSINE; HUMANS; NANOCAPSULES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84924918369     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.01.005     Document Type: Article

References (30)

1. Dykewicz M.S., Hamilos D.L. Rhinitis and sinusitis. J Allergy Clin Immunol 2010, 125:S103-S115.
2. Anon J.B. Upper respiratory infections. Am J Med 2010, 123:S16-S25.
3. Pugliese A. Methicillin-resistant Staphylococcus aureus and chronic sinusitis. Internet J Infect Dis 2009, 9:9.
4. Karchmer A.W. Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US-an update. Clin Infect Dis 2004, 39:S142-S150.
5. Young B.C., Golubchik T., Batty E.M., Fung R., Larner-Svensson H., et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci USA 2012, 109:4550-4555.
6. Ryskova L., Buchta V., Slezak R. Photodynamic antimicrobial therapy. Central Eur J Biol 2010, 5:400-406.
7. Wilson M., Dobson J., Sarkar S. Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol 1993, 8:182-187.
8. Williams J., Pearson G., Colles M., Wilson M. The effect of variable energy input from a novel light source on the photoactivated bactericidal action of toluidine blue O on Streptococcus mutans. Caries Res 2003, 37:190-193.
9. Sarkar S., Wilson M. Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodontal Res 1993, 28:204-210.
10. Zanin I.C.J., Gonçalves R.B., Junior A.B., Hope C.K., Pratten J. Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 2005, 56:324-330.
11. Begue W., Bard R., Koehne G. Microbial inhibition by erythrosin. J Dent Res 1966, 45:1464-1467.
12. Baab D., Broadwell A., Williams B. A comparison of antimicrobial activity of four disclosant dyes. J Dent Res 1983, 62:837-841.
13. Marsh P., Bevis R., Newman H., Hallsworth A., Robinson C., et al. Antibacterial activity of some plaque-disclosing agents and dyes. Caries Res 1989, 23:348-350.
14. Wood S., Metcalf D., Devine D., Robinson C. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother 2006, 57:680-684.
15. Costa A.C.B.P., Campos Rasteiro V.M., da Silva Hashimoto E.S.H., Araújo C.F., Pereira C.A., et al. Effect of erythrosine-and LED-mediated photodynamic therapy on buccal candidiasis infection of immunosuppressed mice and Candida albicans adherence to buccal epithelial cells. Oral Surg Oral Med Oral Pathol Oral Radiol 2012, 114:67-74.
16. Usacheva M.N., Teichert M.C., Biel M.A. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against Gram-positive and Gram-negative microorganisms. Lasers Surg Med 2001, 29:165-173.
17. Wainwright M., Phoenix D., Laycock S., Wareing D., Wright P. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998, 160:177-181.
18. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998, 42:13-28.
19. Boddu S.H., Jwala J., Vaishya R., Earla R., Karla P.K., et al. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocul Pharmacol Ther 2010, 26:37-48.
20. Vangara K.K., Liu J.L., Palakurthi S. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res 2013, 33:2425-2434.
21. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
22. Lee C.-M. Nanoparticle mobility in viscoelastic media. ProQuest 2008, 196.
23. Amorena B., Gracia E., Monzón M., Leiva J., Oteiza C., et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 1999, 44:43-55.
24. Garg A.D., Bose M., Ahmed M.I., Bonass W.A., Wood S.R. In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells. PLoS ONE 2012, 7:e34475.
25. ® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech 2010, 11:1250-1256.
26. Shen H., Hu X., Szymusiak M., Wang Z.J., Liu Y. Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. Mol Pharm 2013, 10:4546-4551.
27. Alexis N., Soukup J., Ghio A., Becker S. Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol 2000, 97:21-32.
28. Yang C.-Y., Tai M.-F., Lin C.-P., Lu C.-W., Wang J.-L., et al. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS ONE 2011, 6:e25524.
29. Vargas A., Delie F. Potential use of biodegradable nanoparticles for the photodynamic therapy of eye diseases. Arch Soc Esp Oftalmol 2009, 84:169-176.
30. Matthews E., Mesler D. Photodynamic effects of erythrosine on the smooth muscle cells of guinea-pig taenia coli. Br J Pharmacol 1984, 83:555-566.